Microchimerism and systemic sclerosis

International Archives of Allergy and Immunology

Volumn 125, Issue 3, 2001, Pages 196-202

  Scaletti, Cristina ^a,b   Vultaggio, A ^a   Maggi, E ^a   Romagnani, S ^a   Piccinni, M P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

Microchimerism; Pregnancy; Systemic sclerosis

Indexed keywords

AUTOANTIBODY;

CELL INFILTRATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; HUMAN; INFLAMMATORY CELL; MICROCHIMERISM; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCLEROSIS; SKIN DEFECT; SKIN FIBROSIS; T LYMPHOCYTE ACTIVATION; TH2 CELL;

CHIMERA; CHRONIC DISEASE; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0034907318     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053816     Document Type: Review

References (66)

1. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
2. Epidemiology of systemic sclerosis
3. Occupational and environmental influences on scleroderma
4. Genetics of scleroderma
5. Retrovirus and the pathogenesis of systemic sclerosis
6. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells
7. Increased collagen synthesis by scleroderma fibroblasts in vitro: A possible defect in the regulation or activation of the scleroderma fibroblast
8. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology
9. DNA topoisomerases
10. DNA topoisomerase I is involved in both repression and activation of transcription
11. Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations
12. Cellular infiltrates in scleroderma skin
13. Mononuclear cell-fibroblast interactions in scleroderma
14. Immunological analysis of bronchoalveolar lavage (BAL) cells from scleroderma patients and control
15. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma
16. Th1 and Th2 cells: Different patterns of lymphokine secretions lead to different functional properties
17. Lymphokine production by human T cells in disease state
18. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines
19. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells
20. Type 2 helper T cell predominance and high CD30 expression in systemic sclerosis
21. IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: Relationship between vimentin and CD23
22. Human fibroblasts synthesize elevated cells of extracellular matrix proteins in response to interleukin 4
23. Eosinophil activation in systemic sclerosis
24. Increased dermal mast cell population in progressive systemic sclerosis: A link in chronic fibrosis?
25. Human basophil releasability VIII. Increased basophil releasability in patients with scleroderma
26. Scleroderma-like graft-versus-host disease as a late consequence of bone marrow grafting
27. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma
28. Sclerodermatous chronic graft-versus-host disease
29. Chronic graft versus host disease
30. Graft versus host disease
31. Homologous disease in the adult rat, a model for autoimmune disease
32. Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: Clinical correlation and histocompatibility locus antigen association
33. Preferential activation of Th2 cells in chronic graft versus host reaction
34. Cellular pathology of cutaneous graft versus host disease
35. Histamine release of mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes
36. Maternal-fetal immunology and autoimmune disease: Is some autoimmune disease auto-alloimmune or allo-autoimmune?
37. Natural killer cells fertile with receptors for HLA-G?
38. The Th1/Th2 paradigm and allograft response
39. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon?
40. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions
41. The maintenance of pregnancy is associated with predominance of Th2-type cytokines
42. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy
43. Relaxin favors the development of activated human T cells into Th1-like effectors
44. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones
45. Practical and theoretical implications of fetal-maternal lymphocyte transfer
46. Fetal leukocytes in the maternal circulation after delivery
47. Two-way cell traffic between mother and fetus: Biologic and clinical implications
48. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization
49. Trophoblast cells in peripheral blood from pregnant women
50. Microchimerism in pregnant mice
51. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-term microchimerism in severe trauma patients
52. A new case of human chimerism detected after pregnancy: 46,XY karyotype in the lymphocytes of a woman
53. Microchimerism of maternal origin persists into adult life
54. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
55. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
56. Microchimerism in human diseases
57. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: A controlled study
58. Scleroderma
59. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma
60. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease
61. Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis
62. New perspectives in the etiology of systemic sclerosis
63. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens
64. Cutting edge: Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: Implications in autoimmunity
65. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride